Inside the science of Non-surgical brain-computer interfaces With Scott Meek, PhD R&D Director and Co-Founder of Subs
What if you could connect your brain to a computer without the need for surgery or permanent implants in your head? A startup called Subsense is pursuing this vision with a radically different approach to brain-computer interfaces. Their technology utilizes nanoparticles—administered through the nose—that interact with neural activity, combined with a device capable of reading and stimulating brain signals.
This approach could open up new possibilities for treating neurological disorders, including Parkinson’s disease, while simultaneously laying the groundwork for entirely innovative forms of interaction between humans, computers, and artificial intelligence. However, reaching this goal will require overcoming significant scientific challenges—from delivering nanoparticles to precise locations within the brain to ensuring the safe and reliable reading and modulation of neural activity. As the field of brain-computer interfaces (BCI) advances, serious ethical questions will also arise, particularly regarding the protection of privacy, autonomy, and freedom of thought.
Join us for a conversation with Scott Meek, Head of Research and Development at Subsense, as he explains the science behind this emerging technology, the breakthroughs researchers are pursuing, and the obstacles that still remain. We will explore what it will take to transition from early laboratory results to practical medical treatments—and, eventually, toward a reality where the boundary between the human brain and digital technology becomes far less rigid.
Free registration
Thursday, November 12, 8 a.m. (Pacific Time)